Designed around the way
your specialty works.
Therapeutic episode with formulation, safety planning, longitudinal symptoms and carefully governed sensitive information.
Assess presenting concerns, psychiatric/medical history, mental state, substance use, social context and the patient’s own goals.
Record diagnosis and formulation separately; build collaborative care and crisis/safety plans with named contacts and review dates.
Track psychotherapy sessions, medication monitoring, inpatient/community transitions and multidisciplinary responsibilities.
Support age-appropriate instruments, consent, safeguarding and disclosure restrictions without hiding essential emergency information from authorized clinicians.
Diagnosis coverage and clinical records
Depressive, anxiety, bipolar, psychotic, trauma-related, substance-use and neurodevelopmental disorders; self-harm/suicide concerns as clinically assessed phenomena. Distinguish positive screening from diagnosis and avoid treating a risk score as a prediction of an individual act.
Measurements that give the record meaning
| Measurement | Units / representation | Clinical context |
|---|---|---|
| Symptom scores | instrument/component score | Version, language, respondent and timeframe |
| Mental state | structured narrative/categorical | Appearance, cognition, thought, affect and context |
| Safety assessment | clinician formulation | Current concerns, protective factors, access to means and plan |
| Medication monitoring | kg; mmHg; laboratory-specific units | Drug-specific indication and schedule |
| Substance use | quantity/frequency | Substance, route, last use and source |
| Sleep/function | hours; named scale | Patient report, instrument and baseline |
| Treatment engagement | sessions; dates | Attendance, patient preference and reason for interruption |
Equipment and integration plans
- Teleconsultation and patient questionnaires → consented records with identity checks; wearables are optional contextual data.
- ECT/rTMS systems, if offered, → treatment session parameters and reports through approved export; never remote energy control through a general EMR.
Connections require an approved interface and testing against the installed manufacturer, model and software. Listed equipment is a candidate integration target.
Explore equipment & roboticsReporting and meaningful outcomes
Follow-up after discharge, care-plan review, symptom/function change and engagement with declared populations; measure alert follow-through rather than claiming suicide prediction.
Development scope and clinical validation
Initial scope
Assessment, formulation, care/safety plans, session notes and medicines.
Advanced scope
Telehealth/questionnaire integration and specialty treatment records after access controls are proven.
Example acceptance scenarios
- Sensitive note restrictions must be tested against portal, print, export, search and emergency-access paths.
- A questionnaire indicating acute concern must enter the locally approved human response pathway; automated scoring alone cannot close the case.
Research foundations
Research snapshot: 23 September 2026. References inform the proposed design; they do not certify FertPro or establish device compatibility. Diagnosis lists and measurement groups are not treatment protocols.